ArticleBlood advances2021

CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials.

Chezi Ganzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.